Alembic Pharmaceuticals informs about press release

26 Dec 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. The company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

973.00 9.05 (0.94%)
15-May-2024 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1524.60
Dr. Reddys Lab 5937.15
Cipla 1413.00
Zydus Lifesciences 998.75
Lupin 1630.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.